CONMED Corporation

CONMED Corporation

CNMD·NYSE

$33.06

-2.3%
HealthcareMedical - Devices

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

At a Glance

Live Snapshot
Market Cap$995.41M
EPS1.5200
P/E Ratio21.75
Earnings Date07/29/2026

cnmd

Operating Cash Flow

Last Annual Value

170.69M

3-Year CAGR

72%

5-Year CAGR

21%

10-Year CAGR

14%

CONMED Corporation

CONMED Corporation Competitors Analysis of Operating Cash Flow

CNMD · NYSE
CompanyOperating Cash Flow
CAGR 3Y
CAGR 5Y
CAGR 10Y
170.69M
10.8%8.8%16.1% 
601.77M
7.8%16.9%35.0%
58.24M
12.4%-6.4%5.1%
-77.61M
N/AN/AN/A
91.91M
30.5%45.1%25.6%
NVCR logo
NovoCure Limited
NASDAQ:NVCR
-49.03M
N/AN/AN/A
-348.88M
N/AN/AN/A
-18.54M
N/AN/AN/A
AZTA logo
Azenta, Inc.
NASDAQ:AZTA
72.18M
131.3%-13.6%6.2%
CONMED Corporation

CONMED Corporation Fair Value Envelope

CNMD · NYSE

Our analysis suggests that CNMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $33.06, this represents a potential HIDDEN relative to our calculated worth for CONMED Corporation.

Intrinsic Value
Current Price: $33.06